Acetylcysteine use appears to impair blood coagulation and reduce platelet aggregation

2006 ◽  
Vol &NA; (1088) ◽  
pp. 5
Author(s):  
&NA;
1975 ◽  
Vol 13 (11) ◽  
pp. 41-43

Two preparations of dextran have been tried for prevention of venous thromboembolic disease, dextran-40 (average m. w. 40,000) and dextran-70 (average m.w. 70,000). Dextrans reduce platelet aggregation and lower blood viscosity.1 Dextran may also reduce the peri-operative rise in the coagulation factors V and VIII.2 However, in some tests dextrans increase platelet aggregation3 and accelerate fibrin formation,4 so that only clinical trial can show whether dextran reduces the incidence of either deep-vein thrombosis or of pulmonary embolism.


2018 ◽  
Vol 172 ◽  
pp. 142-149 ◽  
Author(s):  
Tomoaki Oda ◽  
Naoaki Tamura ◽  
Yi Shen ◽  
Yukiko Kohmura-Kobayashi ◽  
Naomi Furuta-Isomura ◽  
...  

1969 ◽  
Vol 22 (3) ◽  
pp. 304-311 ◽  
Author(s):  
N. MacKay ◽  
J. C. Ferguson ◽  
G. P. McNicol

2011 ◽  
Vol 19 (2) ◽  
pp. 218-223 ◽  
Author(s):  
Hyun-Jeong Cho ◽  
Sun-A Choi ◽  
Chun-Gyu Kim ◽  
Tae-Sung Jung ◽  
Jeong-Hwa Hong ◽  
...  

1969 ◽  
Vol 16 (5) ◽  
pp. 487-500 ◽  
Author(s):  
E. E. Nishizawa ◽  
T. Hovig ◽  
F. Lotz ◽  
H. C. Rowsell ◽  
J. F. Mustard

Sign in / Sign up

Export Citation Format

Share Document